| Financial Year |
March 31 2023 |
| Monetary Funds |
1,457,140,291.61 |
| Held-for-trading Financial Assets |
172,007,965.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
44,975,025.36 |
| Advances to Suppliers |
21,479,250.97 |
| Other Receivables |
7,297,588.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
98,537.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,441,849.03 |
| Total Current Assets |
1,735,440,508.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,189,506.78 |
| Investment Properties |
170,103,432.07 |
| Fixed Assetes |
264,961,162.78 |
| Under-construction Projects |
84,341,023.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,490,261.27 |
| R&D expenses |
-- |
| Goodwill |
241,207,816.11 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
18,913,171.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,163,381,856.36 |
| Total Assets |
2,898,822,364.99 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
43,407,868.98 |
| Accounts Received In Advance |
3,886,403.13 |
| Employee Compensation Payable |
24,307,588.05 |
| Taxes Payable |
4,992,618.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
108,102,219.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,012,188.71 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
436,116,798.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,283,727.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,491,479.09 |
| Total Liabilities |
442,608,277.42 |
| Paid-In Capital(Or Share Stock) |
245,762,900.00 |
| Capital Surplus |
876,088,854.70 |
| Surplus Reserve |
135,450,983.67 |
| LESS:Treasury Stock |
119,485,780.16 |
| Undistributed Profits |
1,312,066,957.17 |
| Minority Stockholder's Interest |
8,303,694.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,447,910,393.00 |
| Owner's Equity（Stockholder's Equity） |
2,456,214,087.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,898,822,364.99 |
